All the news Showing 10 of 217 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir Medicines Patent Pool / 21 April 2017 WHO prequalifies first generic active ingredient for hepatitis C medicines World Health Organization / 05 April 2017 France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment Intellectual Property Watch / 03 April 2017 Pharma could take NHS England to court over new delaying tactics PharmaPhorum / 27 March 2017 Industry links with patient organisations BMJ / 27 March 2017 Regulator defends hepatitis charity criticised on BBC show Third Sector / 02 March 2017 Hepatitis C drugs re-energize global fight over patents Nature / 01 March 2017 Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs ProPublica / 27 February 2017 More bottles of fake hepatitis C meds found at Tokyo wholesalers The Mainichi / 25 January 2017 Two new hepatitis C therapies fast-tracked in Europe PMLive / 25 January 2017 ← Prev1...56789...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds